The problem was the side effects associated, particularly with GLP-1, are what we call peak to trough: so the difference between the highest amount of drug and the lowest and then going back up again to the highest caused by this twice-a-day dosingwhich you can imagine someone bouncing around maybe two to three times, the drug at peak, then trough, causes a lot of GI distress
Learn more about our Mounjaro programme or read our expert guides for more helpful information
Basic skincare recommendations (gentle cleansing, moisturizer, and sunscreen) after significant weight loss is not very different than before the weight loss
Results Clinical Characteristics and Treatment Results A total of 52 T2D patients treated with either liraglutide ( n = 22) or dulaglutide ( n = 30) were enrolled in this study from June, 2019 to Dec, 2020 ( Table 1 , Supplementary Figure 1 ), with 34 and 18 patients defined as responders and non-responders, respectively